Using Metformin to Treat Ulcerative Colitis

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the use of Metformin as an additional therapy for patients suffering from ulcerative colitis, a chronic inflammatory bowel disease. The study aims to explore the potential benefits of Metformin in improving treatment outcomes for patients with mild to moderate forms of the condition. Participants will be adults aged 18 and older who have been diagnosed with ulcerative colitis and meet specific inclusion criteria. The trial will exclude individuals with severe disease or other significant health issues that could interfere with the study.

Why it matters

Who can join: the full rules

Inclusion Criteria:

\- Age ≥ 18 years Both males and females will be included Negative pregnancy test and effective contraception Mild and moderate UC patients diagnosed and confirmed by the endoscope

Exclusion Criteria:

\- Breastfeeding Significant liver and kidney function abnormalities Diabetic patients Colorectal cancer patients Patients with severe UC Patients taking rectal or systemic steroids

Where it's running

• Faculty of Medicine, Mansoura University
  Al Mansurah, Egypt Recruiting

Study contacts

• Study coordinator: Mostafa Bahaa, PhD
• Email: mbahaa@horus.edu.eg
• Phone: 0201025538337

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Long-Term Guselkumab Use in Adults with Inflammatory Bowel Disease

  This study looks at how long adults with Crohn's disease or ulcerative colitis stay on guselkumab in real-world care.

  Recruiting Janssen Research & Development, LLC · Amiens · NCT07822529

• Intestinal ultrasound-guided management for inflammatory bowel disease

  This study tests if adding point-of-care intestinal ultrasound at every visit changes treatment decisions for adults with Crohn’s disease or ulcerative colitis undergoing disease assessment.

  Recruiting Mahidol University · Bangkok · NCT07775352

• Resting energy use in kids with inflammatory bowel disease

  This multicenter study will test the resting energy expenditure of children aged 6–17 with new IBD diagnoses to see how it relates to disease activity and treatment.

  Recruiting Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria · Alessandria, Piedmont · NCT07670975

• Active video education by disease subtype to improve bowel prep before colonoscopy

  We’re testing whether adding subtype-specific video education to standard prep improves bowel cleanliness in adults with IBD undergoing colonoscopy.

  Recruiting at 12 sites Xijing Hospital of Digestive Diseases · Beijing, BeijingBeijing and 11 other locations · NCT07582731

• Intestinal ultrasound to predict relapse in Crohn's disease patients in deep remission.

  This project will try to see if a noninvasive transabdominal ultrasound can predict relapses in adults with Crohn's disease who are currently in deep remission.

  Recruiting Nanfang Hospital, Southern Medical University · Guangzhou, Guangdong · NCT07539727

• Ath-063: Testing a new treatment for moderately to severely active ulcerative colitis in patients who have tried other biologics

  This study tests ATH-063 to see if it helps people with moderate to severe ulcerative colitis who did not respond to or relapsed after prior biologic therapy.

  Recruiting at 4 sites Phase 2 Athos Therapeutics Inc · Miami, Florida and 3 other locations · NCT07513181

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.